AVTE - Aerovate Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-40.66M

Cash

99.33M

Avg Qtr Burn

-17.26M

Short % of Float

8.29%

Insider Ownership

0.03%

Institutional Own.

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AV-101 Details Pulmonary arterial hypertension	Phase 2/3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.